Related Experiment Video
Updated: Feb 26, 2026

06:01
Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization
Published on: June 7, 2016
7.1K
miRNAs in Normal and Malignant Hematopoiesis.
Ryutaro Kotaki1, Ryo Koyama-Nasu2, Natsuko Yamakawa3
1Department of Hematology and Oncology, Tokai University School of Medicine, Hiratsuka 259-1193, Japan. kotaki-r@k-lab.jp.
International Journal of Molecular Sciences
|July 12, 2017
Summary
MicroRNAs (miRNAs) are key regulators of cell fate during B-cell development. This review explores their role in B-cell malignancies, highlighting their potential as diagnostic and therapeutic tools.
Area of Science:
- Molecular Biology
- Hematopoiesis
- Oncology
Background:
- Cell fate determination is primarily controlled by transcription factors at the transcriptional level.
- MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression post-transcriptionally.
- miRNAs play crucial roles in cellular functions, including the regulation of lineage specification in hematopoiesis.
Purpose of the Study:
- To review the critical roles of miRNAs in normal B-cell development.
- To examine the involvement of miRNAs in the pathogenesis of B-cell malignancies.
- To discuss the potential of miRNAs as biomarkers for disease prognosis and therapeutic targets in B-cell cancers.
Main Methods:
- Literature review of scientific publications on miRNAs and B-cell development/malignancies.
- Analysis of existing data correlating miRNA expression profiles with clinical outcomes.
- Discussion of current and emerging therapeutic strategies targeting miRNAs.
Main Results:
- miRNAs are essential regulators of B-cell lineage specification and differentiation.
- Altered miRNA expression is frequently observed in various B-cell malignancies.
- Specific miRNA profiles correlate with disease phenotypes, prognoses, and patient outcomes.
Conclusions:
- miRNAs are integral to B-cell development and are implicated in B-cell cancers.
- miRNA expression patterns offer valuable prognostic and diagnostic information for B-cell malignancies.
- Targeting miRNAs presents a promising avenue for novel therapeutic interventions in B-cell oncology.
Related Concept Videos
MicroRNAs
4.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs
24.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
Hematopoiesis
9.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
9.3K
Role of Hematopoietic Growth Factors
4.1K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
4.1K
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Regulation of Hematopoietic Stem Cells
4.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.2K

